Neurocrine (1NBIX) Ownership - Who Owns Neurocrine?
Neurocrine (1NBIX) Ownership Overview
- 1.14% Insiders
- 25.65% Mutual Funds
- 3.64% Other Institutional Investors
- 32.54% ETFs
- 37.03% Public Companies and Individual Investors
The ownership structure of Neurocrine (IT:1NBIX) stock is a mix of institutional, retail, and individual investors. Approximately 61.83% of the company’s stock is owned by Institutional Investors, 1.14% is owned by Insiders, and 37.03% is owned by Public Companies and Individual Investors.
The ownership structure of Neurocrine (IT:1NBIX) stock is a mix of institutional, retail, and individual investors. Approximately 61.83% of the company’s stock is owned by Institutional Investors, 1.14% is owned by Insiders, and 37.03% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 13,711,607 | Institution | 13.49% | 2,019,061,554 |
| Ishares | 12,462,544 | Institution | 12.26% | 1,835,134,529 |
| Vanguard | 8,798,186 | Institution | 8.66% | 1,295,550,485 |
| Vanguard Index Funds | 7,980,917 | Institution | 7.85% | 1,175,205,990 |
| John A. Gunn | 5,584,707 | Institution | 5.49% | 822,359,275 |
| Dodge & Cox Funds | 4,419,163 | Institution | 4.35% | 650,730,590 |
| Spdr | 3,206,614 | Institution | 3.15% | 472,180,325 |
| Jpmorgan | 1,807,706 | Institution | 1.78% | 266,188,324 |
| J.p. Morgan Mutual Fund Investment Trust | 1,358,475 | Institution | 1.34% | 200,038,161 |
| Invesco | 1,126,944 | Institution | 1.11% | 165,944,758 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 7,980,917 | Institution | 7.85% | 1,175,205,990 |
| Dodge & Cox Funds | 4,419,163 | Institution | 4.35% | 650,730,590 |
| J.p. Morgan Mutual Fund Investment Trust | 1,358,475 | Institution | 1.34% | 200,038,161 |
| Jpmorgan Trust Ii | 1,116,674 | Institution | 1.10% | 164,432,480 |
| Fidelity Concord Street Trust | 993,422 | Institution | 0.98% | 146,283,376 |
| Vanguard Horizon Funds | 673,925 | Institution | 0.66% | 99,236,804 |
| Vanguard Explorer Fund | 637,614 | Institution | 0.63% | 93,889,937 |
| Fidelity Salem Street Trust | 618,394 | Institution | 0.61% | 91,059,753 |
| Tiaa-cref Funds | 468,475 | Institution | 0.46% | 68,983,881 |
| Carillon Series Trust | 370,409 | Institution | 0.36% | 54,543,466 |
FAQ
Who Owns Neurocrine (IT:1NBIX)?
According to the latest TipRanks data, approximately 61.83% of the company's stock is held by institutional investors, 1.14% is held by insiders, and 37.03% is held by public companies and individual investors.
What percentage of Neurocrine (IT:1NBIX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 61.83% of Neurocrine (IT:1NBIX) stock is held by institutional investors: 25.65% by mutual funds, 32.54% by ETFs and 3.64% by other institutional investors.
What percentage of Neurocrine (IT:1NBIX) stock is held by retail investors?
According to the latest TipRanks data, approximately 37.03% of Neurocrine (IT:1NBIX) stock is held by public companies and individual investors.
Who owns the most shares of Neurocrine (IT:1NBIX)?
BlackRock, Inc. owns the most shares of Neurocrine (IT:1NBIX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
